The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Immunomodulation and Blood Transfusion
Abstract
Over the past three decades, evidence from a variety of sources has suggested that allogeneic blood transfusions can induce clinically significant immunosuppression in recipients. This clinical syndrome is referred to in the transfusion medicine literature as transfusion-associated immunomodulation (TRIM) and has been linked to an improved clinical outcome in the setting of renal transplantation. Possible deleterious TRIM-associated effects include increased prevalence of cancer recurrence and postoperative bacterial infections. The recognition that TRIM can increase morbidity and mortality in allogeneically transfused individuals has become a major concern for those involved in transfusion medicine. Whether TRIM predisposes recipients to increased risk for cancer recurrence and/or bacterial infections is still not proven, however. In contrast to the available clinical data, studies in experimental animal models suggest that TRIM is an immunologically mediated biologic effect associated with the infusion of allogeneic leukocytes, which can be ameliorated by prestorage leukoreduction. Although considerable data have been accumulated in an attempt to unravel the clinically adverse effects of TRIM, the precise mechanism of TRIM has yet to be elucidated. Further studies, both basic and applied, to establish the clinically relevant manifestations of TRIM as well as the mechanism(s) are urgently required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?
Vamvakas, E. C., & Blajchman, M. A. (2001) · Blood · doi:10.1182/blood.v97.5.1180 · Cited by 423
Self-citation
Cited by
Koch, C. G., Li, L., Duncan, A. I., Mihaljevic, T., Cosgrove, D. M., Loop, F. D., Starr, N. J., & Blackstone, E. H. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217920.48559.d8 · Cited by 936
Waselenko, J. K., MacVittie, T. J., Blakely, W. F., Pesik, N., Wiley, A. L., Dickerson, W. E., Tsu, H., Confer, D. L., Coleman, C. N., Seed, T., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-12-200406150-00015 · Cited by 766
Cata, J. P., Wang, H., Gottumukkala, V., Reuben, J., & Sessler, D. I. (2013) · British Journal of Anaesthesia · doi:10.1093/bja/aet068 · Cited by 539
Transfusion in Coronary Artery Bypass Grafting is Associated with Reduced Long-Term Survival
Koch, C. G., Li, L., Duncan, A. I., Mihaljevic, T., Loop, F. D., Starr, N. J., & Blackstone, E. H. (2006) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2005.12.037 · Cited by 510
Surgical Outcomes and Transfusion of Minimal Amounts of Blood in the Operating Room
Ferraris, V. A. (2012) · Archives of Surgery · doi:10.1001/archsurg.2011.790 · Cited by 343
Metadata
- Authors
- Blajchman, M. A.
- Venue
- American Journal of Therapeutics
- Published
- 2002-09
- Volume
- 9
- Issue
- 5
- Pages
- 389-395
- ISSN
- 1075-2765 (ISSN-L)
- OpenAlex
- W2007056023
- Cited by
- 190
- References
- 1
- FWCI
- 4.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Immunomodulation and Blood Transfusion. https://app.cochat.ai/papers/10.1097/00045391-200209000-00005
- The paper
- Blajchman, M. A. (2002). Immunomodulation and Blood Transfusion. American Journal of Therapeutics. https://doi.org/10.1097/00045391-200209000-00005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.